Monitor Q4 2026 results for execution on the Return-to-Growth Action Plan, particularly whether the Wellspect Healthcare momentum broadens to other segments and if operating cash flow recovers from the Q3 trough.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $9.46entry
- T+1 · 8d ago +0.85%α −1.52% · $9.54
- T+5 · 4d ago −3.17%α −5.77% · $9.16
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Dentsply Sirona reported Q3 2026 adjusted EPS of $0.29, missing the $0.31 consensus, on net sales of $836M, below the $861.7M consensus. Revenue declined 7.6% YoY (7.0% constant currency), with all segments except Wellspect Healthcare (up 10.1%) contracting. The company lowered its FY2026 outlook to approximately $3.5B in net sales and adjusted EPS of $1.20-$1.30.
Key Financial Metrics
Key Facts
- Q3 2026 net sales $836M, down 7.6% YoY from $904M
- Q3 2026 adjusted EPS $0.29, down 29.4% YoY from $0.42
- GAAP diluted loss per share ($0.01) vs ($2.14) in Q3 2025
- Adjusted EBITDA $146M, down 13.3% YoY; margin 17.3% vs 18.4%
- Wellspect Healthcare segment grew 10.1% as-reported; all other segments declined
- FY2026 outlook lowered to ~$3.5B net sales and adjusted EPS $1.20-$1.30
- Operating cash flow $32M vs $79M in Q3 2025; free cash flow $0M vs $40M
- Company repurchased 1.2M shares for ~$13M in Q3
Financial Impact
Revenue miss of ~$25.7M vs consensus; adjusted EPS miss of $0.02 vs consensus; FY guidance lowered to $1.20-$1.30 adjusted EPS
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Connected Technology Solutions | $230.0M | -11.0% |
| Essential Dental Solutions | $343.0M | -4.0% |
| Orthodontic and Implant Solutions | $171.0M | -16.6% |
| Wellspect Healthcare | $92.0M | +10.1% |
Risk Factors
- Continued revenue decline in core segments (Connected Technology Solutions -11%, Orthodontic and Implant Solutions -16.6%)
- Operating cash flow deterioration and free cash flow at zero in Q3
- FY2026 guidance implies a weak Q4 to hit the $1.20-$1.30 adjusted EPS range
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3396986 |
Track record
15 reports on XRAY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Bearish 6/10 No price data
- Nov 5, 202611d ago Press Release Bearish 6/10 Viewing Entry $9.46 to $9.16 Now $8.95 +5.39% ▲ +3.17% +5.77% vs SPY
- Nov 5, 202611d ago Institutional Cluster Neutral 2/10 Entry $10.09 to $9.24 Now $8.95 −11.30% ▼ −8.42% −11.71% vs SPY
- Oct 20, 202627d ago Press Release Neutral 1/10 Entry $9.08 Now $8.95 −1.43% No price data
- Oct 9, 20265w ago 8-K Neutral 4/10 Entry $8.53 to $8.42 Now $8.95 +4.92% ▼ −1.29% +0.20% vs SPY
- Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $10.50 to $9.38 Now $8.95 −14.76% ▼ −10.71% −10.22% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 3/10 Entry $10.03 to $10.52 Now $8.95 −10.77% ▲ +4.89% +5.93% vs SPY
- Jun 15, 202622w ago Insider Cluster Neutral 3/10 Entry $10.45 to $10.20 Now $8.95 −14.35% ▼ −2.39% −0.16% vs SPY
- Jun 11, 202622w ago 8-K Neutral 3/10 Entry $10.14 to $10.03 Now $8.95 −11.74% ▼ −1.08% −1.52% vs SPY
- May 5, 202627w ago 8-K Bearish 6/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers